Our findings were consistent with recently reported proteomics data in MYC-amplified medulloblastoma, showing upregulation of the glutathione biosynthetic pathway compared to non-MYC-amplified medulloblastoma and normal brain [54]. This evidence concerns the gene MYC and medulloblastoma.